XENCOR INC (XNCR) — insider trading
Health Care · NASDAQ
XENCOR INC (XNCR) has 22 reported SEC Form 4 insider transactions in our data, including 6 open-market sales among the most recent 22 (latest 2026-06-18).
Recent Form 4 transactions
| Date | Insider | Role | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| 2026-06-18 | Feigal Ellen | Director | Open-market sale | 6,843 | $13.06 | $89.4K | Form 4 |
| 2026-06-16 | Deshaies Raymond Joseph | Director | Grant / award / vesting (derivative) | 20,604 | — | $0 | Form 4 |
| 2026-06-16 | Deshaies Raymond Joseph | Director | Grant / award / vesting | 10,302 | — | $0 | Form 4 |
| 2026-06-16 | SIMPSON TODD E | Director | Grant / award / vesting (derivative) | 20,604 | — | $0 | Form 4 |
| 2026-06-16 | SIMPSON TODD E | Director | Grant / award / vesting | 10,302 | — | $0 | Form 4 |
| 2026-06-16 | RANIERI RICHARD J | Director | Grant / award / vesting (derivative) | 20,604 | — | $0 | Form 4 |
| 2026-06-16 | RANIERI RICHARD J | Director | Grant / award / vesting | 10,302 | — | $0 | Form 4 |
| 2026-06-16 | Montgomery Alan Bruce | Director | Grant / award / vesting (derivative) | 20,604 | — | $0 | Form 4 |
| 2026-06-16 | Montgomery Alan Bruce | Director | Grant / award / vesting | 10,302 | — | $0 | Form 4 |
| 2026-06-16 | Klencke Barbara | Director | Grant / award / vesting (derivative) | 20,604 | — | $0 | Form 4 |
| 2026-06-16 | Klencke Barbara | Director | Grant / award / vesting | 10,302 | — | $0 | Form 4 |
| 2026-06-16 | GUSTAFSON KURT A | Director | Grant / award / vesting (derivative) | 20,604 | — | $0 | Form 4 |
| 2026-06-16 | GUSTAFSON KURT A | Director | Grant / award / vesting | 10,302 | — | $0 | Form 4 |
| 2026-06-16 | GORMAN KEVIN CHARLES | Director | Grant / award / vesting (derivative) | 20,604 | — | $0 | Form 4 |
| 2026-06-16 | GORMAN KEVIN CHARLES | Director | Grant / award / vesting | 10,302 | — | $0 | Form 4 |
| 2026-06-16 | Feigal Ellen | Director | Grant / award / vesting (derivative) | 20,604 | — | $0 | Form 4 |
| 2026-06-16 | Feigal Ellen | Director | Grant / award / vesting | 10,302 | — | $0 | Form 4 |
| 2026-06-15 | Montgomery Alan Bruce | Director | Open-market sale | 5,064 | $12.31 | $62.3K | Form 4 |
| 2026-06-15 | RANIERI RICHARD J | Director | Open-market sale | 5,474 | $12.31 | $67.4K | Form 4 |
| 2026-06-15 | GUSTAFSON KURT A | Director | Open-market sale | 5,474 | $12.31 | $67.4K | Form 4 |
| 2026-06-15 | GORMAN KEVIN CHARLES | Director | Open-market sale | 7,527 | $12.31 | $92.7K | Form 4 |
| 2026-04-10 | Cornelissen Bart Jan | Officer (SR. VICE PRESIDENT & CFO) | Open-market sale | 3,499 | $12.29 | $43.0K | Form 4 |
Ask the chat about XNCR's insider activity →
Transaction types are the SEC Form 4 codes: open-market purchases (P) and sales (S) are the only rows that reflect open-market conviction. Awards/vesting (A), option exercises (M/X/C), shares withheld for taxes (F) and gifts (G) are compensation or mechanical, not buying or selling on the open market. Sales may be planned and non-discretionary (e.g. a Rule 10b5-1 plan); open-market buying is not a recommendation to buy. Informational only — not financial advice.
Source: SEC EDGAR Form 3/4/5. See the full company profile: XENCOR INC (XNCR).
Last updated 2026-06-18 (most recent filing date).
Informational only — NOT financial advice. Insider filings are sourced from SEC EDGAR and shown with their reported dates.